Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

计划入组 15,000 人 · 首次发布于 2014 年 10 月 1 日

ASO Treatment for Syndromic Craniosynostoses

计划入组 12 人 · 首次发布于 2026 年 4 月 17 日

MicroRNA-150 and microRNA-155 in Multiple Sclerosis

计划入组 140 人 · 首次发布于 2020 年 3 月 9 日

MiRNA Site-Blocking Oligonucleotides(University of Pennsylvania)

microRNA-124

MicroRNA-29

Assia Chemical Industries Ltd. - Teva Tech Site

Israel

A.O.U. SAN LUIGI GONZAGA

Italy

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)

China

Harness Therapeutics Launches MISBA Duo Platform for Dual-Target Neurodegenerative Disease Treatment

Harness Therapeutics Advances First-in-Class Huntington's Disease Drug HRN001 Toward Clinical Trials

MiraDx and UCLA to Present Groundbreaking Research on MicroRNA-Based Predictive Biomarkers at ASCO 2025